TZ

Tinghu Zhang

DI Dana-Farber Cancer Institute: 44 patents #7 of 1,343Top 1%
SP Syros Pharmaceuticals: 1 patents #39 of 53Top 75%
University Of Texas System: 1 patents #2,951 of 6,559Top 45%
📍 Brookline, MA: #66 of 3,196 inventorsTop 3%
🗺 Massachusetts: #1,415 of 88,656 inventorsTop 2%
Overall (All Time): #61,674 of 4,157,543Top 2%
46
Patents All Time

Issued Patents All Time

Showing 1–25 of 46 patents

Patent #TitleCo-InventorsDate
12415816 Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof Nathanael S. Gray, Yao Liu, Mingfeng Hao, David Weinstock, Loretta Sze-Mun Li 2025-09-16
12365664 Small molecule inhibitors of SRC tyrosine kinase Nathanael S. Gray, Guangyan Du, Nathaniel Henning, Suman Rao, Kenneth Dale Westover +1 more 2025-07-22
12365677 Degraders that target proteins via KEAP1 Nathanael S. Gray, Eric Fischer, Guangyan Du, Nozhat Safaee, Nathaniel Henning +1 more 2025-07-22
12281126 Inhibitors of cyclin-dependent kinase 7 and uses thereof Nathanael S. Gray, Nicholas Paul Kwiatkowski, Jie Jiang, Mingfeng Hao, Zhixiang He 2025-04-22
12234220 Immunomodulatory compounds Nathanael S. Gray, Eric Fischer, Alyssa Verano, Zhixiang He, Guangyan Du +4 more 2025-02-25
12227488 Small molecule degraders of Helios and methods of use Alyssa Verano, Eric Wang, Radoslaw Nowak, Jing Yuan, Nathanael S. Gray +2 more 2025-02-18
12168663 Inhibitors of cyclin-dependent kinase 7 (CDK7) Nathanael S. Gray, Yanke Liang, Nicholas Paul Kwiatkowski 2024-12-17
12110292 Ligands to cereblon (CRBN) Nathanael S. Gray, Eric Fischer, Zhixiang He, Guangyan Du, Katherine Donovan +2 more 2024-10-08
12098154 Inhibitors of cyclin-dependent kinases Nathanael S. Gray, Nicholas Paul Kwiatkowski 2024-09-24
12060366 Bispecific degraders Nathanael S. Gray, Eric Fischer, Alyssa Verano, Zhixiang He, Guangyan Du +3 more 2024-08-13
12030892 CRBN modulators Nathanael S. Gray, Eric Fischer, Alyssa Verano, Zhixiang He, Guangyan Du +3 more 2024-07-09
11932625 Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof Nathanael S. Gray, Baishan Jiang, Nicholas Paul Kwiatkowski 2024-03-19
11858897 Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK John Hatcher, Nathanael S. Gray, Hwangeun Choi, Pasi Janne 2024-01-02
11827636 Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use Nathanael S. Gray, Calla M. Olson, Yanke Liang, Nicholas Paul Kwiatkowski 2023-11-28
11807606 Sulfonamide derivatives for protein degradation Nathanael S. Gray, Eric Fischer, Hojong Yoon, Tyler Faust, Katherine Donovan +2 more 2023-11-07
11771697 Small molecule degraders of polybromo-1 (PBRM1) Eric Fischer, Nathanael S. Gray, Radoslaw Nowak, Katherine Donovan, Yao Liu 2023-10-03
11530219 Ligands to cereblon (CRBN) Nathanael S. Gray, Eric Fischer, Zhixiang He, Guangyan Du, Katherine Donovan +2 more 2022-12-20
11505560 Heterobifunctional compounds with improved specificity Radoslaw Nowak, Eric Fischer, Nathanael S. Gray, Zhixiang He, Brian Groendyke 2022-11-22
11325910 Inhibitors of cyclin-dependent kinases Nathanael S. Gray, Nicholas Paul Kwiatkowski 2022-05-10
11306070 Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof Nathanael S. Gray, Baishan Jiang, Nicholas Paul Kwiatkowski 2022-04-19
11279707 NEK inhibitors and methods of use Nathanael S. Gray, Quan Cai 2022-03-22
11247991 Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use Nathanael S. Gray, Calla M. Olson, Yanke Liang, Nicholas Paul Kwiatkowski 2022-02-15
11155556 Pyrimido-diazepinone kinase scaffold compounds and methods for treating PI3K-mediated disorders Nathanael S. Gray, Fleur M. Ferguson, Jean Zhao, Jing Ni 2021-10-26
11149032 Inhibitors of mutant isocitrate dehydrogenases and compositions and methods thereof Jianwei Che 2021-10-19
11142507 Inhibitors of cyclin-dependent kinases Nathanael S. Gray, Nicholas Paul Kwiatkowski, Mingfeng Hao 2021-10-12